SAFEGUARD SCIENTIFICS INC
SFESOTCFinancials · Investors, NEC · PA · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$1.2M | −$1.2M | −$2.5M | −$3.5M | −$3.1M | −$5.6M |
| Net income | −$3.5M | −$6.7M | $17.6M | −$16.0M | $21.7M | −$6.2M |
| Total assets | $22.8M | $37.7M | $54.0M | $69.0M | $107.6M | $145.7M |
| Total liabilities | $2.9M | $3.1M | $3.5M | $6.2M | $5.8M | $78.8M |
| Equity | $20.0M | $34.6M | $50.6M | $62.9M | $101.7M | $67.0M |
| EPS (diluted) | $-0.22 | $-0.40 | $0.84 | $-0.77 | $1.05 | $-0.30 |
| Shares out. | 16.3M | 16.6M | 20.9M | 20.7M | 20.7M | 20.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- —
- Return on equity
- −17.4%
- Return on assets
- −15.3%
- Return on capital (ROCE)
- −5.7%
- Liabilities / assets
- 12.5%
- Debt / equity
- 0.14×
- Book value / share
- $1.23
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -95.49distress
- Accruals / assets
- −0.8%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Manko Joseph M. Jr.Director | Jan 30, 2024 | Grant | 38,087 | $0.71 |
| Demont Ross DDirector | Jan 30, 2024 | Grant | 20,775 | $0.71 |
| Michelson BethDirector | Jan 30, 2024 | Grant | 22,506 | $0.71 |
| Glass Russell DDirector | Jan 30, 2024 | Grant | 20,775 | $0.71 |
| Salzman EricOfficer — Chief Executive Officer | Dec 15, 2023 | Grant | 125,000 | $0.00 |
| Salzman EricOfficer — Chief Executive Officer | Nov 15, 2023 | Tax withholding | 5,318 | $1.00 |
| Manko Joseph M. Jr.Director | Oct 16, 2023 | Grant | 26,266 | $1.11 |
| Salzman EricOfficer — Chief Executive Officer | Oct 16, 2023 | Tax withholding | 5,298 | $1.11 |
| Demont Ross DDirector | Oct 16, 2023 | Grant | 14,327 | $1.11 |
| Michelson BethDirector | Oct 16, 2023 | Grant | 15,521 | $1.11 |
| Glass Russell DDirector | Oct 16, 2023 | Grant | 14,327 | $1.11 |
| Salzman EricOfficer — Chief Executive Officer | Sep 15, 2023 | Tax withholding | 5,298 | $1.13 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 53,701 | 3.0 | -12.3% |
| Apr 30, 2026 | 61,271 | 1.4 | +26.5% |
| Apr 15, 2026 | 48,423 | 4.0 | -3.5% |
| Mar 31, 2026 | 50,167 | 1.0 | +22.8% |
| Mar 13, 2026 | 40,866 | 1.0 | -8.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventFeb 12, 2024
- Delisting / listing-standard notice · Regulation FD disclosureFeb 2, 2024
- Delisting / listing-standard notice · Regulation FD disclosure · Other material eventJan 22, 2024
- Director / officer change · Regulation FD disclosure · Other material eventJan 5, 2024
- Entered a material agreement · Delisting / listing-standard notice · Director / officer change · Shareholder vote · Regulation FD disclosure · Other material eventDec 18, 2023
- Other material eventDec 8, 2023
- Results of operationsNov 2, 2023
- Director / officer change · Regulation FD disclosure · Other material eventOct 5, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-KFORM 10-KMar 26, 2024
- 15-12GFeb 20, 2024
- SC 13E3/AFeb 20, 2024
- EFFECTFeb 16, 2024
- SC 13G/AFeb 14, 2024
- SC 13G/AFeb 14, 2024
- SC 13G/AFeb 12, 2024
- 8-KFORM 8-KFeb 12, 2024
- POS AMFeb 9, 2024
- S-8 POSFeb 9, 2024
- S-8 POSFeb 9, 2024
- S-8 POSFeb 9, 2024
- S-8 POSFeb 9, 2024
- 8-KFORM 8-KFeb 2, 2024
- 25Feb 2, 2024